Nicotinamide Ribose Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Pharmaceutical Grade, Food Grade); Application (Energy Metabolism, Cellular Repair, Healthy Aging, Others); Distribution Channel (Hospitals and Retail Pharmacies, Online Distribution), and Geography

Report Code: TIPRE00018993 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Nicotinamide ribose is also known as niagen. It is an alternative form of vitamin B3; hence it is also known as niacin. It is further converted into nicotinamide adenine dinucleotide (NAD+), a coenzyme or helper molecule. The NAD+ levels in the body are associated with health factors such as aging and chronic diseases such as diabetes, heart disease, Alzheimer's disease, and vision loss. The primary function of NAD+ is to act as a fuel for many vital biological processes.

MARKET DYNAMICS

The nicotinamide ribose market growth is estimated to grow due to the growing geriatric population, increasing product development, and rising demand for dietary supplements. The market is expected to have vital growth opportunities in the developing regions owing to rising demand for advanced healthcare and wellness products. Growing investment for research and developments in pharmaceutical industry.

MARKET SCOPE

The "Nicotinamide Ribose Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of nicotinamide ribose market with detailed market segmentation by type, application, and distribution channel. The nicotinamide ribose market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in nicotinamide ribose market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The nicotinamide ribose market is segmented on the basis of type, application, and distribution channel. Based on type, the market is classified as pharmaceutical grade, and food grade. Based on application, the market is segmented as energy metabolism, cellular repair, healthy aging, and others. On the basis of distribution channel, the market is segmented as hospitals and retail pharmacies, and online distribution.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the nicotinamide ribose market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nicotinamide ribose market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nicotinamide ribose market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nicotinamide ribose market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the nicotinamide ribose market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from nicotinamide ribose market are anticipated to have lucrative growth opportunities in the future with the rising demand for nicotinamide ribose market in the global market. Below mentioned is the list of few companies engaged in the nicotinamide ribose market.

The report also includes the profiles of key players in nicotinamide ribose market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  ChromaDex Corp.
  •  Elysium Health, Inc.
  •  Thorne
  •  BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
  •  Solgar
  •  ProHealth, Inc
  •  Genex Formulas
  •  Cytoplan Ltd
  •  NOW Foods
  •  Zhejiang Dazhan Biotechnology Co., Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nicotinamide Ribose Market - By Type
1.3.2 Nicotinamide Ribose Market - By Application
1.3.3 Nicotinamide Ribose Market - By Distribution Channel
1.3.4 Nicotinamide Ribose Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NICOTINAMIDE RIBOSE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NICOTINAMIDE RIBOSE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NICOTINAMIDE RIBOSE MARKET - GLOBAL MARKET ANALYSIS
6.1. NICOTINAMIDE RIBOSE - GLOBAL MARKET OVERVIEW
6.2. NICOTINAMIDE RIBOSE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NICOTINAMIDE RIBOSE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHARMACEUTICAL GRADE
7.3.1. Overview
7.3.2. Pharmaceutical Grade Market Forecast and Analysis
7.4. FOOD GRADE
7.4.1. Overview
7.4.2. Food Grade Market Forecast and Analysis
8. NICOTINAMIDE RIBOSE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ENERGY METABOLISM
8.3.1. Overview
8.3.2. Energy Metabolism Market Forecast and Analysis
8.4. CELLULAR REPAIR
8.4.1. Overview
8.4.2. Cellular Repair Market Forecast and Analysis
8.5. HEALTHY AGING
8.5.1. Overview
8.5.2. Healthy Aging Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. NICOTINAMIDE RIBOSE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospitals and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE DISTRIBUTION
9.4.1. Overview
9.4.2. Online Distribution Market Forecast and Analysis
10. NICOTINAMIDE RIBOSE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Nicotinamide Ribose Market Overview
10.1.2 North America Nicotinamide Ribose Market Forecasts and Analysis
10.1.3 North America Nicotinamide Ribose Market Forecasts and Analysis - By Type
10.1.4 North America Nicotinamide Ribose Market Forecasts and Analysis - By Application
10.1.5 North America Nicotinamide Ribose Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Nicotinamide Ribose Market Forecasts and Analysis - By Countries
10.1.6.1 United States Nicotinamide Ribose Market
10.1.6.1.1 United States Nicotinamide Ribose Market by Type
10.1.6.1.2 United States Nicotinamide Ribose Market by Application
10.1.6.1.3 United States Nicotinamide Ribose Market by Distribution Channel
10.1.6.2 Canada Nicotinamide Ribose Market
10.1.6.2.1 Canada Nicotinamide Ribose Market by Type
10.1.6.2.2 Canada Nicotinamide Ribose Market by Application
10.1.6.2.3 Canada Nicotinamide Ribose Market by Distribution Channel
10.1.6.3 Mexico Nicotinamide Ribose Market
10.1.6.3.1 Mexico Nicotinamide Ribose Market by Type
10.1.6.3.2 Mexico Nicotinamide Ribose Market by Application
10.1.6.3.3 Mexico Nicotinamide Ribose Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Nicotinamide Ribose Market Overview
10.2.2 Europe Nicotinamide Ribose Market Forecasts and Analysis
10.2.3 Europe Nicotinamide Ribose Market Forecasts and Analysis - By Type
10.2.4 Europe Nicotinamide Ribose Market Forecasts and Analysis - By Application
10.2.5 Europe Nicotinamide Ribose Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Nicotinamide Ribose Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Nicotinamide Ribose Market
10.2.6.1.1 Germany Nicotinamide Ribose Market by Type
10.2.6.1.2 Germany Nicotinamide Ribose Market by Application
10.2.6.1.3 Germany Nicotinamide Ribose Market by Distribution Channel
10.2.6.2 France Nicotinamide Ribose Market
10.2.6.2.1 France Nicotinamide Ribose Market by Type
10.2.6.2.2 France Nicotinamide Ribose Market by Application
10.2.6.2.3 France Nicotinamide Ribose Market by Distribution Channel
10.2.6.3 Italy Nicotinamide Ribose Market
10.2.6.3.1 Italy Nicotinamide Ribose Market by Type
10.2.6.3.2 Italy Nicotinamide Ribose Market by Application
10.2.6.3.3 Italy Nicotinamide Ribose Market by Distribution Channel
10.2.6.4 Spain Nicotinamide Ribose Market
10.2.6.4.1 Spain Nicotinamide Ribose Market by Type
10.2.6.4.2 Spain Nicotinamide Ribose Market by Application
10.2.6.4.3 Spain Nicotinamide Ribose Market by Distribution Channel
10.2.6.5 United Kingdom Nicotinamide Ribose Market
10.2.6.5.1 United Kingdom Nicotinamide Ribose Market by Type
10.2.6.5.2 United Kingdom Nicotinamide Ribose Market by Application
10.2.6.5.3 United Kingdom Nicotinamide Ribose Market by Distribution Channel
10.2.6.6 Rest of Europe Nicotinamide Ribose Market
10.2.6.6.1 Rest of Europe Nicotinamide Ribose Market by Type
10.2.6.6.2 Rest of Europe Nicotinamide Ribose Market by Application
10.2.6.6.3 Rest of Europe Nicotinamide Ribose Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Nicotinamide Ribose Market Overview
10.3.2 Asia-Pacific Nicotinamide Ribose Market Forecasts and Analysis
10.3.3 Asia-Pacific Nicotinamide Ribose Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Nicotinamide Ribose Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Nicotinamide Ribose Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Nicotinamide Ribose Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Nicotinamide Ribose Market
10.3.6.1.1 Australia Nicotinamide Ribose Market by Type
10.3.6.1.2 Australia Nicotinamide Ribose Market by Application
10.3.6.1.3 Australia Nicotinamide Ribose Market by Distribution Channel
10.3.6.2 China Nicotinamide Ribose Market
10.3.6.2.1 China Nicotinamide Ribose Market by Type
10.3.6.2.2 China Nicotinamide Ribose Market by Application
10.3.6.2.3 China Nicotinamide Ribose Market by Distribution Channel
10.3.6.3 India Nicotinamide Ribose Market
10.3.6.3.1 India Nicotinamide Ribose Market by Type
10.3.6.3.2 India Nicotinamide Ribose Market by Application
10.3.6.3.3 India Nicotinamide Ribose Market by Distribution Channel
10.3.6.4 Japan Nicotinamide Ribose Market
10.3.6.4.1 Japan Nicotinamide Ribose Market by Type
10.3.6.4.2 Japan Nicotinamide Ribose Market by Application
10.3.6.4.3 Japan Nicotinamide Ribose Market by Distribution Channel
10.3.6.5 South Korea Nicotinamide Ribose Market
10.3.6.5.1 South Korea Nicotinamide Ribose Market by Type
10.3.6.5.2 South Korea Nicotinamide Ribose Market by Application
10.3.6.5.3 South Korea Nicotinamide Ribose Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Nicotinamide Ribose Market
10.3.6.6.1 Rest of Asia-Pacific Nicotinamide Ribose Market by Type
10.3.6.6.2 Rest of Asia-Pacific Nicotinamide Ribose Market by Application
10.3.6.6.3 Rest of Asia-Pacific Nicotinamide Ribose Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Nicotinamide Ribose Market Overview
10.4.2 Middle East and Africa Nicotinamide Ribose Market Forecasts and Analysis
10.4.3 Middle East and Africa Nicotinamide Ribose Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Nicotinamide Ribose Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Nicotinamide Ribose Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Nicotinamide Ribose Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Nicotinamide Ribose Market
10.4.6.1.1 South Africa Nicotinamide Ribose Market by Type
10.4.6.1.2 South Africa Nicotinamide Ribose Market by Application
10.4.6.1.3 South Africa Nicotinamide Ribose Market by Distribution Channel
10.4.6.2 Saudi Arabia Nicotinamide Ribose Market
10.4.6.2.1 Saudi Arabia Nicotinamide Ribose Market by Type
10.4.6.2.2 Saudi Arabia Nicotinamide Ribose Market by Application
10.4.6.2.3 Saudi Arabia Nicotinamide Ribose Market by Distribution Channel
10.4.6.3 U.A.E Nicotinamide Ribose Market
10.4.6.3.1 U.A.E Nicotinamide Ribose Market by Type
10.4.6.3.2 U.A.E Nicotinamide Ribose Market by Application
10.4.6.3.3 U.A.E Nicotinamide Ribose Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Nicotinamide Ribose Market
10.4.6.4.1 Rest of Middle East and Africa Nicotinamide Ribose Market by Type
10.4.6.4.2 Rest of Middle East and Africa Nicotinamide Ribose Market by Application
10.4.6.4.3 Rest of Middle East and Africa Nicotinamide Ribose Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Nicotinamide Ribose Market Overview
10.5.2 South and Central America Nicotinamide Ribose Market Forecasts and Analysis
10.5.3 South and Central America Nicotinamide Ribose Market Forecasts and Analysis - By Type
10.5.4 South and Central America Nicotinamide Ribose Market Forecasts and Analysis - By Application
10.5.5 South and Central America Nicotinamide Ribose Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Nicotinamide Ribose Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Nicotinamide Ribose Market
10.5.6.1.1 Brazil Nicotinamide Ribose Market by Type
10.5.6.1.2 Brazil Nicotinamide Ribose Market by Application
10.5.6.1.3 Brazil Nicotinamide Ribose Market by Distribution Channel
10.5.6.2 Argentina Nicotinamide Ribose Market
10.5.6.2.1 Argentina Nicotinamide Ribose Market by Type
10.5.6.2.2 Argentina Nicotinamide Ribose Market by Application
10.5.6.2.3 Argentina Nicotinamide Ribose Market by Distribution Channel
10.5.6.3 Rest of South and Central America Nicotinamide Ribose Market
10.5.6.3.1 Rest of South and Central America Nicotinamide Ribose Market by Type
10.5.6.3.2 Rest of South and Central America Nicotinamide Ribose Market by Application
10.5.6.3.3 Rest of South and Central America Nicotinamide Ribose Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NICOTINAMIDE RIBOSE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NICOTINAMIDE RIBOSE MARKET, KEY COMPANY PROFILES
13.1. CHROMADEX CORP.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ELYSIUM HEALTH, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THORNE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SOLGAR.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PROHEALTH, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GENEX FORMULAS.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CYTOPLAN LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. NOW FOODS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ZHEJIANG DAZHAN BIOTECHNOLOGY CO., LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. ChromaDex Corp.
2. Elysium Health, Inc.
3. Thorne
4. BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
5. Solgar
6. ProHealth, Inc
7. Genex Formulas
8. Cytoplan Ltd
9. NOW Foods
10. Zhejiang Dazhan Biotechnology Co., Ltd.
TIPRE00018993
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking